The addition of rituximab to fludarabine and cyclophosphamide chemotherapy results in a significant improvement in overall survival in patients with newly diagnosed mantle cell lymphoma: results of a randomized UK National Cancer Research Institute trial
Simon Rule, Paul Smith, Peter WM Johnson, Simon Bolam, George Follows, Joanne Gambell, Peter Hillmen, Andrew Jack, Stephen Johnson, Amy A Kirkwood, Anton Kruger, Christopher Pocock, John F Seymour, Milena Toncheva, Jan Walewski, David Linch
Haematologica | FERRATA STORTI FOUNDATION | Published : 2016
Awarded by CR UK
Awarded by Cancer Research UK
Awarded by National Institute for Health Research
This trial was funded by CR UK (CRUK/06/013) and conducted by the CR UK and UCL Cancer Trials Centre.